查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1604588

焦慮治療藥物市場：按類型、按應用分類 - 2025-2030 年全球預測

Anxiety Drugs Market by Type (Generic Drugs, Patent Medicine), Application (Help Sleep, Treat Anxiety, Treat Premature Ejaculation) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年焦慮治療藥物市場估值為175.1億美元，預計到2024年將達到190.3億美元，複合年成長率為8.78%，預計到2030年將達到315.6億美元。

焦慮藥物市場的範圍和定義包括用於治療各種焦慮症的藥物，例如整體焦慮症、恐慌症和社交焦慮症。這些藥物主要包括抗憂鬱症、苯二氮平類藥物和抗焦慮藥物。由於生活方式的改變、壓力的增加以及對心理健康問題的認知，全球範圍內焦慮症的盛行率不斷增加，這凸顯了對焦慮藥物的需求。最終用途涵蓋各種最終用戶，包括醫院、診所和研究機構等醫療機構，以及個人零售和線上藥局。影響市場的主要成長要素是心理健康意識的提高、遠距遠端醫療的興起，以及發現副作用更少、療效更好的藥物的研發進步。此外，患有焦慮問題的人口老化也帶來了潛在的成長機會。然而，該市場面臨一些限制，例如與苯二氮平類藥物等某些藥物相關的成癮風險、監管挑戰、潛在副作用以及患者不遵守處方藥物的傾向。為了克服這些挑戰，市場可以透過針對個人化藥物選擇、改進藥物配方以減少副作用以及利用人工智慧進行藥物發現和患者管理來進行創新。公司可以探索與數位健康平台的合作，以提供全面護理解決方案。市場動態是動態的，由持續的研究、監管變化和不斷變化的患者期​​望驅動。為了利用這一點，相關人員應專注於透過線上平台增加可近性，對患者和從業者進行安全使用教育，並投資於非藥物治療等創新以補充藥物治療。這些策略有望有效緩解傳統壁壘帶來的挑戰，並促進市場的永續成長。

主要市場統計
基準年[2023] 175.1億美元
預計年份 [2024] 190.3億美元
預測年份 [2030] 315.6億美元
複合年成長率（%） 8.78%

市場動態：揭示快速發展的焦慮治療市場的關鍵市場洞察

供需的動態交互作用正在改變焦慮治療市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 焦慮和憂鬱症等心理健康問題的盛行率增加
    • 政府加強對憂鬱症和焦慮議題的努力和宣傳活動
    • 精神衛生機構和專業人員數量的增加
  • 市場限制因素
    • 精神衛生服務相關法規
  • 市場機會
    • 擴大新焦慮療法的開發與商業化
    • 增加對精神健康治療的監管核准和投資
  • 市場挑戰
    • 對藥物濫用的擔憂

波特的五力：駕馭焦慮藥物市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解焦慮治療市場的外在影響

外部宏觀環境因素在塑造焦慮治療藥物市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解焦慮治療藥物市場的競爭狀況

對焦慮治療藥物市場的詳細市場佔有率分析可以對供應商的表現進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 焦慮治療藥物市場供應商的定位矩陣績效評估

FPNV 定位矩陣是評估焦慮治療藥物市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議，描繪焦慮治療藥物市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對焦慮治療藥物市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5.產品開發與創新：重點關注可望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 焦慮和憂鬱症等心理健康問題增加
      • 加強政府對憂鬱症和焦慮症的努力和宣傳活動
      • 心理健康機構和專業人員的增加
    • 抑制因素
      • 精神衛生服務相關法規
    • 機會
      • 拓展新業務焦慮症治療藥物
      • 增加對精神健康治療的監管核准和大量投資
    • 任務
      • 對藥物濫用的擔憂
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章焦慮治療藥物市場：依類型

  • 學名藥
  • 專利藥

第7章焦慮治療市場：依應用分類

  • 幫助睡眠
  • 治療焦慮症
  • 早洩的治療

第8章美洲焦慮藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章：亞太地區焦慮藥物市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲的焦慮藥物市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Apotex Inc.
  • AstraZeneca PLC
  • Bausch Health Companies Inc.
  • Chengdu Kanghong Pharmaceutical Group Co., Ltd.
  • Eli Lilly And Company
  • GlaxoSmithKline PLC
  • H. Lundbeck A/S
  • Huahai Pharmaceutical Co. Ltd.
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Otsuka Pharmaceutical Co., Ltd.
  • Pfizer Inc.
  • Sanofi SA
  • Sun Pharmaceuticals Pvt. Ltd.
  • Zhejiang Jianfeng Pharmaceutical Co., Ltd.
  • Zydus Pharmaceuticals（USA）Inc.
Product Code: MRR-434CCDA05209

The Anxiety Drugs Market was valued at USD 17.51 billion in 2023, expected to reach USD 19.03 billion in 2024, and is projected to grow at a CAGR of 8.78%, to USD 31.56 billion by 2030.

The scope and definition of the anxiety drugs market encompass medications that are formulated to treat various anxiety disorders, including generalized anxiety disorder, panic disorder, and social anxiety disorder. These drugs primarily include antidepressants, benzodiazepines, and anxiolytics. The necessity for anxiety drugs is underscored by the growing prevalence of anxiety disorders across the globe, fueled by lifestyle changes, increasing stress, and awareness of mental health issues. Their application spans across different end-users, primarily including healthcare facilities like hospitals, clinics, research institutes, and retail and online pharmacies for individual use. A key growth factor influencing the market is the heightened focus on mental health awareness, the rise of telemedicine, and the progress in R&D to discover drugs with fewer side effects and improved efficacy. Furthermore, an increasing aging population experiencing anxiety issues offers potential growth opportunities. However, the market faces limitations such as the risk of addiction associated with certain drugs like benzodiazepines, regulatory challenges, potential side effects, and a tendency among patients for non-compliance with prescribed medication. To overcome these challenges, the market can innovate by targeting personalized medicine options, advancing drug formulations to reduce side effects, and leveraging AI in drug discovery and patient management. Companies can explore collaborations with digital health platforms to offer integrated care solutions. The anxiety drugs market is dynamic, driven by ongoing research, regulatory changes, and shifting patient expectations. To capitalize on this, stakeholders should focus on increasing accessibility via online platforms, educating patients and practitioners on safe usage, and investing in innovations such as non-pharmacological treatments that can be complementary to medications. These strategies could effectively alleviate the challenges posed by traditional barriers and facilitate sustainable market growth.

KEY MARKET STATISTICS
Base Year [2023] USD 17.51 billion
Estimated Year [2024] USD 19.03 billion
Forecast Year [2030] USD 31.56 billion
CAGR (%) 8.78%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Anxiety Drugs Market

The Anxiety Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of mental health problems such as anxiety and depression
    • Government initiatives and rising awareness campaigns for depression and anxiety issues
    • Rising number of mental health institutions and professionals
  • Market Restraints
    • Laws and regulations regarding mental health services
  • Market Opportunities
    • Expanding development and commercialization of novel anxiety drugs
    • Rising regulatory approvals and high investments in mental health treatment
  • Market Challenges
    • Concerns related to misuse of drugs

Porter's Five Forces: A Strategic Tool for Navigating the Anxiety Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Anxiety Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Anxiety Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Anxiety Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Anxiety Drugs Market

A detailed market share analysis in the Anxiety Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Anxiety Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Anxiety Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Anxiety Drugs Market

A strategic analysis of the Anxiety Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Anxiety Drugs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Apotex Inc., AstraZeneca PLC, Bausch Health Companies Inc., Chengdu Kanghong Pharmaceutical Group Co., Ltd., Eli Lilly And Company, GlaxoSmithKline PLC, H. Lundbeck A/S, Huahai Pharmaceutical Co. Ltd., Johnson & Johnson, Merck & Co. Inc., Otsuka Pharmaceutical Co., Ltd., Pfizer Inc., Sanofi S.A., Sun Pharmaceuticals Pvt. Ltd., Zhejiang Jianfeng Pharmaceutical Co., Ltd., and Zydus Pharmaceuticals (USA) Inc..

Market Segmentation & Coverage

This research report categorizes the Anxiety Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Generic Drugs and Patent Medicine.
  • Based on Application, market is studied across Help Sleep, Treat Anxiety, and Treat Premature Ejaculation.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of mental health problems such as anxiety and depression
      • 5.1.1.2. Government initiatives and rising awareness campaigns for depression and anxiety issues
      • 5.1.1.3. Rising number of mental health institutions and professionals
    • 5.1.2. Restraints
      • 5.1.2.1. Laws and regulations regarding mental health services
    • 5.1.3. Opportunities
      • 5.1.3.1. Expanding development and commercialization of novel anxiety drugs
      • 5.1.3.2. Rising regulatory approvals and high investments in mental health treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns related to misuse of drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Anxiety Drugs Market, by Type

  • 6.1. Introduction
  • 6.2. Generic Drugs
  • 6.3. Patent Medicine

7. Anxiety Drugs Market, by Application

  • 7.1. Introduction
  • 7.2. Help Sleep
  • 7.3. Treat Anxiety
  • 7.4. Treat Premature Ejaculation

8. Americas Anxiety Drugs Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Anxiety Drugs Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Anxiety Drugs Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Apotex Inc.
  • 3. AstraZeneca PLC
  • 4. Bausch Health Companies Inc.
  • 5. Chengdu Kanghong Pharmaceutical Group Co., Ltd.
  • 6. Eli Lilly And Company
  • 7. GlaxoSmithKline PLC
  • 8. H. Lundbeck A/S
  • 9. Huahai Pharmaceutical Co. Ltd.
  • 10. Johnson & Johnson
  • 11. Merck & Co. Inc.
  • 12. Otsuka Pharmaceutical Co., Ltd.
  • 13. Pfizer Inc.
  • 14. Sanofi S.A.
  • 15. Sun Pharmaceuticals Pvt. Ltd.
  • 16. Zhejiang Jianfeng Pharmaceutical Co., Ltd.
  • 17. Zydus Pharmaceuticals (USA) Inc.

LIST OF FIGURES

  • FIGURE 1. ANXIETY DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. ANXIETY DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ANXIETY DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ANXIETY DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ANXIETY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ANXIETY DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ANXIETY DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ANXIETY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ANXIETY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ANXIETY DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ANXIETY DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ANXIETY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ANXIETY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANXIETY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANXIETY DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ANXIETY DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ANXIETY DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ANXIETY DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ANXIETY DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ANXIETY DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ANXIETY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ANXIETY DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ANXIETY DRUGS MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ANXIETY DRUGS MARKET SIZE, BY PATENT MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ANXIETY DRUGS MARKET SIZE, BY HELP SLEEP, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ANXIETY DRUGS MARKET SIZE, BY TREAT ANXIETY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ANXIETY DRUGS MARKET SIZE, BY TREAT PREMATURE EJACULATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ANXIETY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ANXIETY DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ANXIETY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ANXIETY DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM ANXIETY DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM ANXIETY DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ANXIETY DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 101. ANXIETY DRUGS MARKET, FPNV POSITIONING MATRIX, 2023